David Shoukry Yassa, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Equipment Contamination | 2 | 2017 | 182 | 0.260 |
Why?
|
| o-Phthalaldehyde | 1 | 2017 | 15 | 0.150 |
Why?
|
| Duodenoscopy | 1 | 2017 | 45 | 0.150 |
Why?
|
| Ethylene Oxide | 1 | 2017 | 28 | 0.150 |
Why?
|
| Equipment Reuse | 1 | 2017 | 45 | 0.140 |
Why?
|
| Bacteriophage T4 | 1 | 1997 | 33 | 0.140 |
Why?
|
| Duodenoscopes | 1 | 2017 | 43 | 0.140 |
Why?
|
| Ethambutol | 1 | 2017 | 59 | 0.140 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 2017 | 76 | 0.140 |
Why?
|
| Guideline Adherence | 2 | 2018 | 2220 | 0.140 |
Why?
|
| Sterilization | 1 | 2017 | 133 | 0.140 |
Why?
|
| Tuberculosis, Osteoarticular | 1 | 2016 | 26 | 0.130 |
Why?
|
| Microbiological Techniques | 1 | 2017 | 97 | 0.130 |
Why?
|
| Disinfectants | 1 | 2017 | 130 | 0.130 |
Why?
|
| Candida | 1 | 2017 | 172 | 0.130 |
Why?
|
| Sparganosis | 1 | 2015 | 4 | 0.130 |
Why?
|
| Spirometra | 1 | 2015 | 4 | 0.130 |
Why?
|
| Disinfection | 1 | 2017 | 211 | 0.120 |
Why?
|
| Candidiasis | 1 | 2017 | 365 | 0.110 |
Why?
|
| Prosthesis-Related Infections | 2 | 2017 | 488 | 0.110 |
Why?
|
| Cross Infection | 3 | 2018 | 1422 | 0.110 |
Why?
|
| Optic Nerve Diseases | 1 | 2017 | 342 | 0.110 |
Why?
|
| Knee Prosthesis | 1 | 2016 | 395 | 0.110 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2017 | 587 | 0.100 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2017 | 636 | 0.100 |
Why?
|
| Breast Diseases | 1 | 2015 | 442 | 0.100 |
Why?
|
| Influenza Vaccines | 1 | 2019 | 768 | 0.100 |
Why?
|
| Mastitis | 1 | 2011 | 43 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2020 | 1390 | 0.100 |
Why?
|
| Retinal Ganglion Cells | 1 | 2017 | 811 | 0.090 |
Why?
|
| Catheterization, Central Venous | 1 | 2015 | 527 | 0.090 |
Why?
|
| Infectious Disease Medicine | 1 | 2010 | 49 | 0.090 |
Why?
|
| Viral Proteins | 1 | 1997 | 1804 | 0.080 |
Why?
|
| Heart Arrest | 1 | 2020 | 1514 | 0.080 |
Why?
|
| Spine | 1 | 2016 | 1118 | 0.080 |
Why?
|
| Intensive Care Units | 3 | 2018 | 3745 | 0.080 |
Why?
|
| Influenza, Human | 1 | 2019 | 1521 | 0.080 |
Why?
|
| Abscess | 1 | 2011 | 606 | 0.070 |
Why?
|
| Defibrillators, Implantable | 1 | 2017 | 1490 | 0.070 |
Why?
|
| Disease Outbreaks | 1 | 2017 | 1749 | 0.070 |
Why?
|
| Surgical Wound Infection | 1 | 2016 | 1527 | 0.070 |
Why?
|
| Antiviral Agents | 1 | 2019 | 3060 | 0.070 |
Why?
|
| Patient-Centered Care | 1 | 2016 | 1421 | 0.060 |
Why?
|
| Infection Control | 3 | 2018 | 981 | 0.060 |
Why?
|
| Education, Medical, Continuing | 1 | 2010 | 823 | 0.060 |
Why?
|
| Medical Informatics | 1 | 2010 | 733 | 0.050 |
Why?
|
| Staphylococcus aureus | 1 | 2011 | 1458 | 0.050 |
Why?
|
| Staphylococcal Infections | 1 | 2011 | 1408 | 0.050 |
Why?
|
| Membrane Proteins | 2 | 1997 | 7856 | 0.050 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2016 | 3763 | 0.040 |
Why?
|
| Oseltamivir | 1 | 2019 | 75 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 15842 | 0.040 |
Why?
|
| Soaps | 1 | 2018 | 29 | 0.040 |
Why?
|
| Internet | 1 | 2010 | 3092 | 0.040 |
Why?
|
| Chymotrypsin | 1 | 1997 | 138 | 0.040 |
Why?
|
| Mycobacterium avium Complex | 1 | 2017 | 60 | 0.040 |
Why?
|
| Cellulose | 1 | 1997 | 118 | 0.030 |
Why?
|
| Academic Medical Centers | 2 | 2018 | 2759 | 0.030 |
Why?
|
| Gases | 1 | 2017 | 204 | 0.030 |
Why?
|
| Bacteriological Techniques | 1 | 2017 | 275 | 0.030 |
Why?
|
| Food Parasitology | 1 | 2015 | 6 | 0.030 |
Why?
|
| Laminectomy | 1 | 2016 | 225 | 0.030 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2020 | 339 | 0.030 |
Why?
|
| Hygiene | 1 | 2016 | 94 | 0.030 |
Why?
|
| Praziquantel | 1 | 2015 | 34 | 0.030 |
Why?
|
| Anura | 1 | 2015 | 80 | 0.030 |
Why?
|
| Catalysis | 1 | 1997 | 774 | 0.030 |
Why?
|
| Boston | 2 | 2020 | 9326 | 0.030 |
Why?
|
| Antiparasitic Agents | 1 | 2015 | 42 | 0.030 |
Why?
|
| Retreatment | 1 | 2017 | 598 | 0.030 |
Why?
|
| Foodborne Diseases | 1 | 2015 | 41 | 0.030 |
Why?
|
| DNA, Single-Stranded | 1 | 1997 | 355 | 0.030 |
Why?
|
| Health Personnel | 2 | 2019 | 3335 | 0.030 |
Why?
|
| Food Contamination | 1 | 2015 | 191 | 0.030 |
Why?
|
| KB Cells | 1 | 1993 | 13 | 0.030 |
Why?
|
| Judgment | 1 | 2015 | 273 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 1997 | 835 | 0.030 |
Why?
|
| Prosthesis Implantation | 1 | 2017 | 592 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 1997 | 1519 | 0.030 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2020 | 992 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2018 | 1188 | 0.020 |
Why?
|
| Logistic Models | 2 | 2016 | 13255 | 0.020 |
Why?
|
| Hand | 1 | 2016 | 902 | 0.020 |
Why?
|
| Humans | 15 | 2020 | 761504 | 0.020 |
Why?
|
| China | 1 | 2015 | 2369 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1997 | 3734 | 0.020 |
Why?
|
| Antitubercular Agents | 1 | 2017 | 1375 | 0.020 |
Why?
|
| Middle Aged | 6 | 2020 | 220895 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 58976 | 0.020 |
Why?
|
| Drug Resistance | 1 | 1993 | 1596 | 0.020 |
Why?
|
| Spinal Fusion | 1 | 2016 | 1286 | 0.020 |
Why?
|
| Female | 7 | 2020 | 392644 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 10766 | 0.010 |
Why?
|
| Postpartum Period | 1 | 2011 | 1173 | 0.010 |
Why?
|
| Time Factors | 2 | 2017 | 39967 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1997 | 5112 | 0.010 |
Why?
|
| Aged | 4 | 2020 | 169289 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2016 | 9646 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 2015 | 2628 | 0.010 |
Why?
|
| HIV Infections | 1 | 2010 | 17351 | 0.010 |
Why?
|
| Risk Factors | 3 | 2016 | 74206 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12059 | 0.010 |
Why?
|
| Breast | 1 | 2011 | 1967 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 1993 | 3702 | 0.010 |
Why?
|
| Male | 5 | 2020 | 360804 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2017 | 54425 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 7407 | 0.010 |
Why?
|
| Adult | 4 | 2017 | 221177 | 0.010 |
Why?
|
| Young Adult | 2 | 2017 | 59243 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1997 | 9606 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2020 | 80636 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2011 | 22176 | 0.010 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 1993 | 122 | 0.010 |
Why?
|
| Physicians | 1 | 2010 | 4591 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2011 | 26198 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 1993 | 565 | 0.010 |
Why?
|
| Pregnancy | 1 | 2011 | 29874 | 0.010 |
Why?
|
| United States | 1 | 2017 | 72334 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 41487 | 0.000 |
Why?
|
| Protein Kinase C | 1 | 1993 | 1202 | 0.000 |
Why?
|
| Adolescent | 1 | 2016 | 88319 | 0.000 |
Why?
|
| Doxorubicin | 1 | 1993 | 2224 | 0.000 |
Why?
|
| Blotting, Western | 1 | 1993 | 5035 | 0.000 |
Why?
|
| Phosphoproteins | 1 | 1993 | 2448 | 0.000 |
Why?
|
| Animals | 1 | 2015 | 168459 | 0.000 |
Why?
|
| Phosphorylation | 1 | 1993 | 8320 | 0.000 |
Why?
|
| Gene Expression | 1 | 1993 | 7581 | 0.000 |
Why?
|